Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Ferro

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|July 19, 2012
Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitorsLaura De Luca, Stefania Ferro, Francesca Morreale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 18, 2013
Synthesis and biological evaluation of novel antiviral agents as protein-protein interaction inhibitorsStefania Ferro, Laura De Luca, Francesca Morreale, et al.
Chemical & Pharmaceutical Bulletin|December 9, 2010
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsantsRosaria Gitto, Laura De Luca, Stefania Ferro, et al.
Bioorganic & Medicinal Chemistry|January 3, 2018
Structural optimization of N<sub>1</sub>-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strainsAnna Maria Monforte, Laura De Luca, Maria Rosa Buemi, et al.
European Journal of Medicinal Chemistry|January 14, 2011
HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigationLaura De Luca, Sara De Grazia, Stefania Ferro, et al.
Journal of Chemical Information and Modeling|February 6, 2007
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitorsMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
International Journal of Molecular Sciences|August 12, 2023
Fighting <i>Pseudomonas aeruginosa</i> Infections: Antibacterial and Antibiofilm Activity of D-Q53 CecB, a Synthetic Analog of a Silkworm Natural Cecropin B VariantIrene Varponi, Stefania Ferro, Luca Menilli, et al.
Bioorganic & Medicinal Chemistry|August 8, 2018
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screeningStefania Ferro, Rosaria Gitto, Maria Rosa Buemi, et al.
Biomacromolecules|July 30, 2009
Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activityStefania Ferro, Giulio Jori, Salvatore Sortino, et al.
Bioorganic & Medicinal Chemistry|June 1, 2017
Searching for novel N<sub>1</sub>-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitorsStefania Ferro, Maria Rosa Buemi, Laura De Luca, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Enzyme Inhibition and Medicinal Chemistry|July 19, 2012
Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitorsLaura De Luca, Stefania Ferro, Francesca Morreale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 18, 2013
Synthesis and biological evaluation of novel antiviral agents as protein-protein interaction inhibitorsStefania Ferro, Laura De Luca, Francesca Morreale, et al.
Chemical & Pharmaceutical Bulletin|December 9, 2010
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsantsRosaria Gitto, Laura De Luca, Stefania Ferro, et al.
Bioorganic & Medicinal Chemistry|January 3, 2018
Structural optimization of N<sub>1</sub>-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strainsAnna Maria Monforte, Laura De Luca, Maria Rosa Buemi, et al.
European Journal of Medicinal Chemistry|January 14, 2011
HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigationLaura De Luca, Sara De Grazia, Stefania Ferro, et al.
Journal of Chemical Information and Modeling|February 6, 2007
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitorsMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
International Journal of Molecular Sciences|August 12, 2023
Fighting <i>Pseudomonas aeruginosa</i> Infections: Antibacterial and Antibiofilm Activity of D-Q53 CecB, a Synthetic Analog of a Silkworm Natural Cecropin B VariantIrene Varponi, Stefania Ferro, Luca Menilli, et al.
Bioorganic & Medicinal Chemistry|August 8, 2018
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screeningStefania Ferro, Rosaria Gitto, Maria Rosa Buemi, et al.
Biomacromolecules|July 30, 2009
Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activityStefania Ferro, Giulio Jori, Salvatore Sortino, et al.
Bioorganic & Medicinal Chemistry|June 1, 2017
Searching for novel N<sub>1</sub>-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitorsStefania Ferro, Maria Rosa Buemi, Laura De Luca, et al.
Pageof 8